Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues

Medical Oncology

Volumn 31, Issue 2, 2014, Pages

  Ahani, Narges ^a   Arzenani, Mohsen Karimi ^b   Shirkoohi, Reza ^c   Rokouei, Mohammad ^a   Eskandani, Majid Alipour ^a   Nikravesh, Abbas ^d  

^a UNIVERSITY OF ZABOL   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Expression; Glioblastoma multiforme; HCMV; IGFBP2

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SOMATOMEDIN BINDING PROTEIN 2; STAT3 PROTEIN; IGFBP 2 PROTEIN, HUMAN; IGFBP-2 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CYTOMEGALOVIRUS INFECTION; GENE PRODUCT; GLIOBLASTOMA; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; ADULT; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOMEGALOVIRUS; FEMALE; FOLLOW UP; GENETICS; HUMAN; MALE; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84891794032     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0812-4     Document Type: Article

References (17)

1. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347-50.
2. Cobbs CS. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae. 2011;2(1):10.
3. Yongjun Yu, Alwine JC. Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 30-OH kinase pathway and the cellular kinase Akt. J Virol. 2002;76:3731-8.
4. Caposio P, Orloff SL, Streblow DN. The role of cytomegalovirus in angiogenesis. Virus Res. 2011;157(2):204-11.
5. Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples. J Virol. 2012;86(2):854-64.
6. Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012;14(3):246-55.
7. Hollon TC, Price RL, Kwon CH, Chiocca EA. Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus. Oncoimmunology. 2013;2(9):e25620.
8. Barami K. Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci. 2010;17:819-23.
9. Fuller G, Rhee C, Hess K, Caskey L, Wang R, Bruner J, Yung A, Zhang W. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res. 1999;59(12):4228-32.
10. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003;63(15):4315-21.
11. Santosh N, Arivazhagan A, Sreekanthreddy P. Grade-specific expression of insulin-like growth factor-binding proteins-2,-3, and-5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Cancer Epidemiol Biomarkers Prev. 2010;19:1399-408.
12. Ahani N, Nikravesh A, Shirkoohi R, Karimi Arzenani M, Rokouei M, Alipour Eskandani M. Detection of human cytomegalovirus in glioma tumor tissues. Comparative Clin Pathol J. 2013; doi:10.1007/s00580-013-1783-8.
13. Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res. 2008;68:724-30.
14. Cinatl J Jr, Kotchetkov R, Scholz M, et al. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol. 1999;155:285-92.
15. Michaelis M, Baumgarten P, Mittelbronn M, Driever PH, Doerr HW, Cinatl J. Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol. 2011;200:1-5.
16. Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem. 2007;282(25):18634-44.
17. Moore L, Holmes M, Smith S, Wu Y, Zhang W. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. PNAS. 2009;106(39):16675-9.